Ethical Risk Mitigation in Artificial Intelligence-Enabled Healthcare

Abstract

As Artificial Intelligence (AI) becomes increasingly integrated into clinical diagnostics, decision support systems, drug discovery, and administrative workflows, its deployment rate has outpaced the development of adequate ethical and governance frameworks. To identify converging strategies for mitigating risks to patient safety, this paper synthesizes recent peer-reviewed literature (2022-2026) on ethical healthcare AI. Guided by systematic reviews, World Health Organization (WHO) guidelines, and emerging empirical bioethics research, we categorize persistent ethical risks into five primary domains: algorithmic bias, privacy and consent, opacity, accountability, and clinician deskilling. We evaluate technical and governance countermeasures -such as federated learning, explainable AI (XAI), adversarial debiasing, human-centered design, and risk-proportional deployment algorithms. Building upon these findings, we propose an integrated, three-layered lifecycle framework (Design, Deployment, and Post-Market Surveillance) that systematically operationalizes risk mitigation. Our analysis demonstrates that single technological solutions are insufficient, and effective risk reduction requires combining algorithmic controls with robust governance frameworks, continuous monitoring, and active clinical oversight.